WebAntiviral Agents for Hepatitis C Virus Initial Authorization Request (Medicaid) Part I. Prior Authorization Criteria and Policy I. Eligibility 1. Patient is enrolled in Texas Medicaid. 2. … WebArchive: Medicaid and CHIP Financial Statistical Reports FY 2024; Managed Care Incentives & Disincentives; Managed Care Organization Sanctions; Texas Medicaid & CHIP - Uniform Managed Care Manual; Medicaid and CHIP Financial Statistical Report Agreed Upon Procedures Results; Medicaid and CHIP Members Menu button for Medicaid and CHIP …

Molina Healthcare of Texas

Web1. Patient is enrolled in Texas Medicaid. 2. The prescribed treatment agent is appropriate for the age of the patient. 3. Patient has a diagnosis of chronic hepatitis C virus (HCV) with a … WebHepatitis C Prior Authorization Criteria and Policy . Texas Medicaid Vendor Drug Program. I. Patient Eligibility • Patient is a Texas Medicaid Patient greater than or equal to 18 years of … immunology and immunotherapy birmingham

EFFECTIVE 1/1/23: Medicaid Hepatitis C Treatment Coverage and …

WebAs of February, 12024, 5,306,617 individuals were enrolled in Medicaid and CHIP. It is estimated that as of 2016, 202,500 people were living with HCV in Texas. WebTexas Vendor Drug Program Antiviral Agents for Hepatitis C Virus Initial Authorization Request (Medicaid) Part I. Prior Authorization Criteria and Policy I. Eligibility 1. Patient is … WebNov 24, 2024 · As a result of the lawsuit, HHSC rewrote its policy, expanding access to DAAs to Medicaid enrollees diagnosed with HCV regardless of liver damage, and removing sobriety and prescriber requirements for HCV treatment. The new policy came into effect on September 1, 2024. immunology ana screen